![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Time to Viral Suppression [week 2/4] Is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Mark Sulkowski1, Michael W Fried2, Resat Ozaras3, Vasily Isakov4, David Wyles5, Peter Ferenci6, Jordan J Feld7, Filipe Calinas8, Michael Gschwantler9, Darrell Crawford10, Ira M Jacobson11,
Barbara McGovern12, Marti n King12, Edward Gane13
1Johns Hopkins University, Baltimore, Maryland, United States; 2University of North Carolina at Chapel Hill, North Carolina, United States; 3Cerrahpasa Medical School, Istanbul, Turkey; 4Institute of Nutrition, Moscow, Russia; 5University of California San Diego, La Jolla, California, United States;
6Universitaetsklinik fuer Innere Medizin III, Vienna, Austria; 7University of Toronto, Toronto, Ontario, Canada; 8Hosp. St. Antonio dos Capuchos, Lisbon, Portugal; 9Wilhelminenspital, Vienna, Austria; 10University of Queensland, Brisbane, Australia;
11Weill Cornell Medical College, New York, New York, United States; 12AbbVie Inc., North Chicago, Illinois, United States; 13Auckland City Hospital, Auckland, New Zealand
......."achievement of SVR12 was not associated with time to viral suppression [week 2 or 4] as assessed by assays examining HCV RNA <25 IU/mL or <15 IU/mL.......Higher baseline HCV RNA level, older age, GT1b subtype, and presence of cirrhosis were associated with a longer time to initial viral suppression <25 IU/mL, but the magnitude of the effect was small and ti me to suppression did not affect achievement of SVR12"
![AASLD1.gif](../images/121714/121714-5/AASLD1.gif)
![AASLD2.gif](../images/121714/121714-5/AASLD2.gif)
![AASLD3.gif](../images/121714/121714-5/AASLD3.gif)
![AASLD4.gif](../images/121714/121714-5/AASLD4.gif)
![AASLD5.gif](../images/121714/121714-5/AASLD5.gif)
![AASLD6.gif](../images/121714/121714-5/AASLD6.gif)
![AASLD7.gif](../images/121714/121714-5/AASLD7.gif)
![AASLD8.gif](../images/121714/121714-5/AASLD8.gif)
![AASLD9.gif](../images/121714/121714-5/AASLD9.gif)
![AASLD10.gif](../images/121714/121714-5/AASLD10.gif)
![AASLD11.gif](../images/121714/121714-5/AASLD11.gif)
![AASLD12.gif](../images/121714/121714-5/AASLD12.gif)
![AASLD13.gif](../images/121714/121714-5/AASLD13.gif)
![AASLD14.gif](../images/121714/121714-5/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|